{
  "kill_screens": {
    "beneish_m_score": {
      "id": "KS-001",
      "name": "Beneish M-Score",
      "threshold": -1.78,
      "operator": ">",
      "fail_condition": "M-Score > -1.78",
      "rationale": "High manipulation probability",
      "applies_to": ["all"],
      "how_to_check": "Calculate from financials or use screening tool"
    },
    
    "altman_z_score": {
      "id": "KS-002",
      "name": "Altman Z-Score",
      "threshold": 1.81,
      "operator": "<",
      "fail_condition": "Z-Score < threshold",
      "rationale": "High bankruptcy probability",
      "applies_to": ["all"],
      "how_to_check": "Calculate from financials or use screening tool",
      "industry_adjustments": {
        "telecom_media": {
          "threshold": 1.5,
          "rationale": "Z-Score designed for manufacturing. Telecom/media have asset-light models with negative working capital by design. Use Piotroski F-Score and debt service metrics as validation.",
          "validation_required": ["piotroski_f_score >= 7", "interest_coverage >= 3x"]
        },
        "biotech_pharma": {
          "threshold": 1.5,
          "rationale": "R&D-heavy companies have lower working capital ratios and negative earnings during development. Evaluate cash runway instead.",
          "validation_required": ["cash_runway >= 18_months", "net_cash_position > 0"]
        },
        "software_saas": {
          "threshold": 2.0,
          "rationale": "Negative working capital is normal for subscription models with deferred revenue. High margins support debt servicing.",
          "validation_required": ["gross_margin >= 60%", "revenue_growth >= 20%"]
        },
        "utilities": {
          "threshold": 2.5,
          "rationale": "High leverage is normal and serviceable due to regulated cash flows.",
          "validation_required": ["interest_coverage >= 2.5x", "regulated_revenue >= 80%"]
        },
        "financials_banks": {
          "threshold": null,
          "rationale": "Z-Score formula inapplicable. Use Tier 1 Capital Ratio (>8%), NPL ratio (<3%), and regulatory capital requirements.",
          "alternative_metrics": ["tier_1_capital_ratio", "npl_ratio", "texas_ratio"]
        }
      },
      "implementation_note": "When company's industry requires adjusted threshold, use both: (1) Adjusted threshold for Z-Score, (2) Validation metrics to confirm financial health. Example: CMCSA Z-Score 1.53 fails standard 1.81 but passes telecom 1.5 AND has Piotroski 9 + interest coverage 5.3x."
    },
    
    "hostile_deal": {
      "id": "KS-003",
      "name": "Hostile Deal",
      "threshold": true,
      "operator": "==",
      "fail_condition": "Deal is hostile/unsolicited",
      "rationale": "38% completion vs 82% friendly",
      "applies_to": ["merger_arb"],
      "how_to_check": "Check deal announcement, target board response"
    },
    
    "merger_spread": {
      "id": "KS-004",
      "name": "Merger Spread Too Narrow",
      "threshold": 2.5,
      "operator": "<",
      "fail_condition": "Spread < 2.5%",
      "rationale": "Historical return only 0.9%",
      "applies_to": ["merger_arb"],
      "how_to_check": "(deal_price - current_price) / current_price"
    },
    
    "macro_conflict": {
      "id": "KS-005",
      "name": "Macro Conflict",
      "threshold": true,
      "operator": "==",
      "fail_condition": "Rate/commodity sensitivity conflicts with legislative thesis",
      "rationale": "Enphase/Albemarle pattern - macro overwhelms legislative tailwind",
      "applies_to": ["legislative"],
      "examples": [
        {"ticker": "ENPH", "conflict": "Rate sensitivity negated IRA benefits"},
        {"ticker": "ALB", "conflict": "Lithium price exposure overwhelmed legislative tailwind"}
      ],
      "how_to_check": "Identify company's macro sensitivities, check if they conflict with thesis"
    },

    "market_cap_ceiling": {
      "id": "KS-006",
      "name": "Market Cap Ceiling",
      "threshold": 50000000000,
      "operator": ">",
      "fail_condition": "Market cap > threshold",
      "rationale": "Framework targets underappreciated special situations. Mega-caps ($50B+) are widely-analyzed institutional plays with lower opportunity density and reduced insider edge.",
      "applies_to": ["all"],
      "archetype_overrides": {
        "merger_arb": {
          "threshold": 100000000000,
          "rationale": "More liquid markets support larger positions"
        },
        "legislative": {
          "threshold": 75000000000,
          "rationale": "Legislative impact often requires scale"
        }
      },
      "how_to_check": "Get latest market cap from financial data provider (Yahoo Finance, SEC filing, or calculate shares_outstanding * current_price)"
    },

    "pdufa_financial_health": {
      "id": "KS-007",
      "name": "PDUFA Financial Health",
      "fail_condition": "Any sub-screen fails",
      "rationale": "PDUFA candidates need runway to survive approval delays, commercialization costs, and potential clinical failure. Generic Z-Score misses biotech-specific risks.",
      "applies_to": ["pdufa"],
      "screens": [
        {
          "metric": "cash_runway_months",
          "threshold": 18,
          "operator": "<",
          "fail_condition": "Cash runway < 18 months",
          "rationale": "Need 18+ months to cover (1) PDUFA delay, (2) CRL resubmission, or (3) pivot to alternative program",
          "calculation": "cash_and_equivalents / (abs(operating_cash_flow_ttm) / 12)"
        },
        {
          "metric": "debt_to_equity",
          "threshold": 0.75,
          "operator": ">",
          "fail_condition": "Debt/Equity > 0.75",
          "rationale": "High leverage limits strategic flexibility if approval delayed or rejected",
          "calculation": "total_debt / shareholders_equity",
          "note": "Ignore if equity is negative (auto-fail on Z-Score anyway)"
        },
        {
          "metric": "gross_margin_pct",
          "threshold": 50,
          "operator": "<",
          "fail_condition": "Gross margin < 50%",
          "rationale": "Need 50%+ gross margin to support SG&A and commercialization costs post-approval",
          "applies_when": "company has revenue (commercial products)",
          "note": "Skip for pure-play development companies with no revenue"
        },
        {
          "metric": "net_cash_position",
          "threshold": 0,
          "operator": "<",
          "fail_condition": "Net debt position (debt > cash)",
          "rationale": "Net debt signals distress and limited financial flexibility",
          "calculation": "cash_and_equivalents - total_debt"
        }
      ],
      "how_to_check": "Extract from latest 10-Q or 10-K. Calculate cash runway using operating cash flow burn rate.",
      "critical_note": "ALL sub-screens must pass. Any single fail = automatic PASS decision.",
      "examples": {
        "pass": {
          "ticker": "Example biotech",
          "cash": "$200M",
          "burn_rate": "$10M/month",
          "runway": "20 months",
          "debt_equity": 0.2,
          "net_cash": "$150M",
          "result": "PASS - All metrics within thresholds"
        },
        "fail": {
          "ticker": "AQST",
          "cash": "$20.28M",
          "burn_rate": "$4.17M/month",
          "runway": "4.9 months",
          "debt_equity": null,
          "net_cash": "$20.28M",
          "result": "FAIL - Runway 4.9mo << 18mo threshold. Z-Score -5.39 already failed."
        }
      }
    },

    "insider_cluster_quality": {
      "id": "KS-008",
      "name": "Insider Cluster Quality",
      "threshold": 3,
      "operator": "<",
      "fail_condition": "Fewer than 3 opportunistic insiders in cluster",
      "rationale": "Routine traders eliminate ~50% of false signals. Only count opportunistic traders toward cluster threshold.",
      "applies_to": ["insider"],
      "how_to_check": "Pull 3-year Form 4 history for each insider. Classify as routine if trades occur in same calendar month annually (3+ years). Count only opportunistic traders toward 3+ threshold.",
      "routine_trader_definition": {
        "pattern": "Trades occur in same calendar month annually",
        "lookback_period_years": 3,
        "example": "Insider sells every June for 3+ years = routine. Exclude from cluster count."
      },
      "implementation": {
        "data_source": "SEC Form 4 via EdgarTools",
        "analysis": "For each insider in cluster: fetch Form 4s from past 3 years, extract transaction dates, check for annual calendar month pattern. If pattern detected, exclude insider from cluster count."
      },
      "examples": {
        "pass": {
          "scenario": "5 insider purchases in 2-week window: 4 opportunistic + 1 routine",
          "opportunistic_count": 4,
          "routine_count": 1,
          "result": "PASS - 4 opportunistic insiders >= 3 threshold"
        },
        "fail": {
          "scenario": "5 insider purchases in 2-week window: 2 opportunistic + 3 routine",
          "opportunistic_count": 2,
          "routine_count": 3,
          "result": "FAIL - 2 opportunistic insiders < 3 threshold"
        }
      }
    }
  },

  "logic": "Any kill screen fail = automatic PASS. Check ALL applicable screens BEFORE scoring."
}
